PTGX
NASDAQStockProtagonist Therapeutics, Inc.
$96.17-0.39 (-0.40%)
52-Week Range
$40.89
$97.05
Key Stats
Market Cap
6.1B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.24
Volume
467.9K
Avg Volume
703.2K
Performance
1M
+13.76%
3M
+0.07%
6M
+63.45%
YTD
+9.45%
1Y
+65.52%
3Y
+275.97%
5Y
+209.50%
Price Chart
ETF Exposure
PTGX is held by 130 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| PSCH | Invesco S&P SmallCap Health Care ETF | 3.46% |
| PBE | Invesco Biotechnology & Genome ETF | 3.18% |
| PTH | Invesco Dorsey Wright Healthcare Momentum ETF | 2.25% |
| BMED | iShares Health Innovation Active ETF | 1.72% |
| RZG | Invesco S&P SmallCap 600 Pure Growth ETF | 1.55% |
| XSMO | Invesco S&P SmallCap Momentum ETF | 1.30% |
| XBI | State Street SPDR S&P Biotech ETF | 1.30% |
| FDMO | FIDELITY MOMENTUM FACTOR ETF | 0.76% |
| BBC | Virtus Biotech Clinical Trials ETF | 0.75% |
| SLYG | State Street SPDR S&P 600 Small Cap Growth ETF | 0.74% |
| IJT | iShares S&P Small-Cap 600 Growth ETF | 0.74% |
| FLQS | Franklin U.S. Small Cap Multifactor Index ETF | 0.67% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 0.66% |
| VAMO | Cambria Value & Momentum ETF | 0.64% |
| SVAL | iShares US Small Cap Value Factor ETF | 0.64% |
| VIOG | Vanguard S&P Small-Cap 600 Growth ETF | 0.61% |
| FYC | First Trust Small Cap Growth AlphaDEX Fund | 0.56% |
| ACSG | American Century Small Cap Growth Insights ETF | 0.54% |
| SCDS | JPMorgan Fundamental Data Science Small Core ETF | 0.54% |
| ETHO | Amplify Etho Climate Leadership U.S. ETF | 0.54% |
| IBB | iShares Biotechnology ETF | 0.50% |
| LOPP | Gabelli Love Our Planet & People ETF | 0.50% |
| DWAS | Invesco Dorsey Wright SmallCap Momentum ETF | 0.49% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.46% |
| MMSC | First Trust Multi-Manager Small Cap Opportunities ETF | 0.45% |
| IWO | iShares Russell 2000 Growth ETF | 0.45% |
| SMMV | iShares MSCI USA Small-Cap Min Vol Factor ETF | 0.44% |
| XJR | iShares ESG Select Screened S&P Small-Cap ETF | 0.44% |
| PSC | Principal U.S. Small-Cap Multi-Factor ETF | 0.43% |
| QVMS | Invesco S&P SmallCap 600 QVM Multi-factor ETF | 0.43% |
| IJR | iShares Core S&P Small-Cap ETF | 0.38% |
| SPSM | State Street SPDR Portfolio S&P 600 Small Cap ETF | 0.38% |
| JMEE | JPMorgan Small & Mid Cap Enhanced Equity ETF | 0.37% |
| AFSM | First Trust Active Factor Small Cap ETF | 0.36% |
| TNXT | T. Rowe Price Innovation Leaders ETF | 0.33% |
| JPSE | JPMorgan Diversified Return U.S. Small Cap Equity ETF | 0.32% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.31% |
| VIOO | Vanguard S&P Small-Cap 600 ETF | 0.31% |
| OASC | OneAscent Small Cap Core ETF | 0.30% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.30% |
| BBSC | JPMorgan BetaBuilders U.S. Small Cap Equity ETF | 0.29% |
| STXK | Strive Small-Cap ETF | 0.29% |
| ROSC | Hartford Multifactor Small Cap ETF | 0.28% |
| BKSE | BNY Mellon US Small Cap Core Equity ETF | 0.28% |
| SAA | ProShares - Ultra SmallCap600 | 0.27% |
| USVM | VictoryShares US Small Mid Cap Value Momentum ETF | 0.27% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.26% |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.25% |
| KBFR | Innovator U.S. Small Cap Managed 10 Buffer ETF | 0.22% |
| CSA | VictoryShares US Small Cap Volatility Wtd ETF | 0.22% |
Page 1 of 3Next
About PTGX ETF Exposure
Protagonist Therapeutics, Inc. (PTGX) is held by 130 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 6.1B, PTGX is a widely held institutional stock. The stock currently trades at $96.17. Investors can gain exposure to PTGX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold PTGX, sorted by portfolio weight.